Long-Acting Injectable Antipsychotic Screening, Utilization, & Effects: The RUHS Medical Center Case Study
Riverside University Health System (RUHS) is an academic, tertiary care medical center and county safety-net facility operating a 77 bed inpatient psychiatric hospital located in Riverside, California. In this short presentation, Dr. Melissa Mitchell and Dr. Andy Williams discuss changes implemented at the RUHS related to long acting injectable (LAI) antipsychotics. The case study focuses on measuring current LAI usage and screening, and barriers encountered with LAI utilization and potential opportunities for alternative strategies for increased utilization opportunities in the …
Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI). Specific PsychU programs may be supported by OPDC, OAPI and other committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsor or the sponsors of the specific PsychU program in which such opinions are expressed. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC and OAPI.